Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2001 Jun;92(6):624–630. doi: 10.1111/j.1349-7006.2001.tb01140.x

Quantitative Analysis of BRCA1 and BRCA2 mRNA Expression in Sporadic Breast Carcinomas and Its Relationship with Clinicopathological Characteristics

Chiyomi Egawa 1, Yasuo Miyoshi 1, Tetsuya Taguchi 1, Yasuhiro Tamaki 1, Shinzaburo Noguchi 1,✉
PMCID: PMC5926755  PMID: 11429050

Abstract

BRCA1 and BRCA2 mRNA expression in sporadic breast cancers was quantified by a real‐time reverse transcriptase‐polymerase chain reaction (RT‐PCR), and the relationship of their expression with various Clinicopathological factors was studied. BRCA2 mRNA levels (0.993±1.395, mean±SD (BRCA2/β‐glucuronidase mRNA ratios)) were significantly (P<0.01) higher than BRCA1 mRNA levels (0.519±0.570 (BRCAl/p‐glucuronidase mRNA ratios)), and a weak but significant (r=0.390, P<0.01) correlation was observed between BRCA1 and BRCA2 mRNA expression levels. There was no significant association between BRCA1 mRNA expression and Clinicopathological factors such as menstrual status, tumor size, lymph node status, estrogen and progesterone receptor status, and histological grade. On the other hand, there was a significant association between higher BRCA2 mRNA expression and estrogen receptor (ER) negativity (P<0.01) or progesterone receptor (PR) negativity (P<0.01) or high histological grade (P<0.01). These results suggest a differential contribution of BRCA1 and BRCA2 in the pathogenesis of sporadic breast cancers. BRCA2 mRNA is speculated to be up‐regulated in response to proliferation and genomic instability in high histological grade tumors.

Keywords: Breast cancer, BRCA1, BRCA2, mRNA expression, RT‐PCR

Full Text

The Full Text of this article is available as a PDF (99.8 KB).

Reference

  • 1.Miki , Y. , Swensen , J. , Shattuck‐Eidens , D. , Futreal , P. A. , Harshman , K. , Tavtigian , S. , Liu , Q. , Cochran , C. , Bennett , L. M. , Ding , W. , Russell , B. , Rosenthal , J. , Hussey , C. , Tran , T. , McClure , M. , Frye , C. , Hattier , T. , Phelps , R. , Haugen‐Strano , A. , Katcher , H. , Yakumo , K. , Gholami , Z. , Shaffer , D. , Stone , S. , Bayer , S. , Wray , C. , Bogden , R. , Dayananth , P. , Ward , J. , Tonin , P. , Narod , S. , Bristow , P. K. , Norris , F. H. , Helvering , L. , Morrison , P. , Rosteck , P. , Lai , M. , Barrett , J. C. , Lewis , C. , Neuhausen , S. , Cannon‐Albright , L. , Goldgar , D. , Wiseman , R. , Kamb , A. and Skolnick , M. H . A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 . Science , 266 , 66 – 71 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 2.Wooster , R. , Neuhausen , S. L. , Mangion , J. , Quirk , Y. , Ford , D. , Collins , N. , Nguyen , K. , Seal , S. , Tran , T. , Averill , D. , Fields , P. , Marshall , G. , Narod , S. , Lenoir , G. M. , Lynch , H. , Feunteun , J. , Devilee , P. , Cornelisse , C. J. , Menko , F. H. , Daly , P. A. , Ormiston , W. , McManus , R. , Pye , C. , Lewis , C. M. , Cannon‐Albright , L. A. , Peto , J. , Ponder , B. A. J. , Skolnick , M. H. , Easton , D. F. , Goldgar , D. E. and Stratton , M. R . Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13ql2‐13 . Science , 265 , 2088 – 2090 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 3.Frank , T. S. , Manley , S. A. , Olopade , O. I. , Cummings , S. , Garber , J. E. , Bernhardt , B. , Antman , K. , Russo , D. , Wood , M. E. , Mullineau , L. , Isaacs , C. , Peshkin , B. , Buys , S. , Venne , V. , Rowley , P. T. , Loader , S. , Offit , K. , Robson , M. , Hampel , H. , Brener , D. , Winer , E. P. , Clark , S. , Weber , B. , Strong , L. C. , Rieger , P. , McClure , M. , Ward , B. E. , Shattuck‐Eidens , D. , Oliphant , A. , Skolnick , M. H. and Thomas , A . Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk . J. Clin. OncoL , 16 , 2417 – 2425 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 4.Couch , F. J. , DeShano , M. L. , Blackwood , M. A. , Calzone , K. , Stopfer , J. , Campeau , L. , Ganguly , A. , Rebbeck , T. and Weber , B. L . BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer . N. Engl. J. Med. , 336 , 1409 – 1415 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 5.Easton , D. F. , Ford , D. and Bishop , D. T . Breast and ovarian cancer incidence in BRCA1‐mutation carriers. Breast Cancer Linkage Consortium . Am. J. Hum. Genet. , 56 , 265 – 271 ( 1995. ). [PMC free article] [PubMed] [Google Scholar]
  • 6.Struewing , J. P. , Hartge , P. , Wacholder , S. , Baker , S. M. , Berlin , M. , McAdams , M. , Timmerman , M. M. , Brody , L. C. and Tucker , M. A . The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ash‐kenazi Jews . N. Engl. J. Med. , 336 , 1401 – 1408 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 7.Ford , D. , Easton , D. F. , Stratton , M. , Narod , S. , Goldgar , D. , Devilee , P. , Bishop , D. T. , Weber , B. , Lenoir , G. , Chang‐Claude , J. , Sabol , H. , Teare , M. D. , Struewing , J. , Arason , A. , Schemeck , S. , Peto , J. , Rebbeck , T. R. , Tonin , P. , Neuhausen , S. , Barkardottir , R. , Eyfjord , J. , Lynch , H. , Ponder , B. A. J. , Gayther , S. A. , Birch , J. M. , Lindblom , A. , Stoppa‐Lyonnet , D. , Bignon , Y. , Borg , A. , Hamann , U. , Haites , N. , Scott , R. J. , Maugard , C. M. , Vasen , H. , Seitz , S. , Cannon‐Albright , L. A. , Schofield , A. , Zelada‐Hedman , M . and the Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families . Am. J. Hum. Genet. , 62 , 676 – 689 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Holt , J. T. , Thompson , M. E. , Szabo , C. , Robinson‐Benion , C. , Arteaga , C. L. , King , M. C. and Jensen , R. A . Growth retardation and tumour inhibition by BRCA1 . Nat. Genet. , 12 , 298 – 302 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 9.Khoo , U. S. , Ozcelik , H. , Cheung , A. N. , Chow , L. W. , Ngan , H. Y. , Done , S. J. , Liang , A. C. , Chan , V. W. , Au , G. K. , Ng , W. F. , Poon , C. S. , Leung , Y. F. , Loong , F. , Ip , P. , Chan , G. S. , Andrulis , I. L. , Lu , J. and Ho , F . C. Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer . Oncogene , 18 , 4643 – 4646 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 10.Weber , B. H. , Brohm , M. , Stec , L , Backe , J. and Caffier , H . A somatic truncating mutation in BRCA2 in a sporadic breast tumor . Am. J. Hum. Genet , 59 , 962 – 964 ( 1996. ). [PMC free article] [PubMed] [Google Scholar]
  • 11.Lancaster , J. M. , Wooster , R. , Mangion , J. , Phelan , C. M. , Cochran , C. , Gumbs , C. , Seal , S. , Barfoot , R. , Collins , N. , Bignell , G. , Patel , S. , Hamoudi , R. , Larsson , C. , Wiseman , R. W. , Berchuck , A. , Iglehart , J. D. , Marks , J. R. , Ashworth , A. , Stratton , M. R. and Futreal , P. A . BRCA2 mutations in primary breast and ovarian cancers . Nat. Genet. , 13 , 238 – 240 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 12.Miki , Y. , Katagiri , T. , Kasumi , F. , Yoshimoto , T. and Nakamura , Y . Mutation analysis in the BRCA2 gene in primary breast cancers . Nat. Genet , 13 , 245 – 247 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 13.Thompson , M. E. , Jensen , R. A. , Obermiller , P. S. , Page , D. L. and Holt , J. T . Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression . Nat. Genet , 9 , 444 – 450 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 14.Rice , J. C. , Massey‐Brown , K. S. and Futscher , B. W . Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells . Oncogene , 17 , 1807 – 1812 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 15.Bieche , I. , Nogues , C. and Lidereau , R . Overexpression of BRCA2 gene in sporadic breast tumours . Oncogene , 18 , 5232 – 5328 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 16.Collins , N. , Wooster , R. and Stratton , M. R . Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers . Br. J. Cancer , 76 , 1150 – 1156 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Seery , L. T. , Knowlden , J. M. , Gee , J. M. , Robertson , J. F. , Kenny , F. S. , Ellis , I. O. and Nicholson , R. I . BRCA1 expression levels predict distant metastasis of sporadic breast cancers . Int. J. Cancer , 84 , 258 – 262 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 18.Merajver , S. D. , Frank , T. S. , Xu , J. , Pham , T. M. , Calzone , K. A. , Bennett‐Baker , P. , Chamberlain , J. , Boyd , J. , Garber , J. E. , Collins , F. S. and Weber , B. L . Germline BRCA1 mutations and loss of the wild‐type allele in tumors from families with early onset breast and ovarian cancer . Clin. Cancer Res. , 1 , 539 – 544 ( 1995. ). [PubMed] [Google Scholar]
  • 19.Noguchi , S. , Kasugai , T. , Miki , Y. , Fukutomi , T. , Emi , M. and Nomizu , T.Clinicopathologic analysis of BRCA1‐ or BRCA2‐associated hereditary breast carcinoma in Japanese women . Cancer , 85 , 2200 – 2205 ( 1999. ). [PubMed] [Google Scholar]
  • 20.Eisinger , F. , Stoppa‐Lyonnet , D. , Longy , M. , Kerangueven , F. , Noguchi , T. , Bailly , C. , Vincent‐Salomon , A. , Jacquemier , J. , Birnbaum , D. and Sobol , H . Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer . Cancer Res. , 56 , 471 – 474 ( 1996. ). [PubMed] [Google Scholar]
  • 21.Sobol , H. , Stoppa‐Lyonnet , D. , Bressac‐de‐Paillerets , B. , Peyrat , J. P. , Kerangueven , F. , Janin , N. , Noguchi , T. , Eisinger , F. , Guinebretiere , J. M. , Jacquemier , J. and Birnbaum , D.Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers . Cancer Res. , 56 , 3216 – 3219 ( 1996. ). [PubMed] [Google Scholar]
  • 22.Ozcelik , H. , To , M. D. , Couture , J. , Bull , S. B. and Andrulis , I. L.Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers . Int. J. Cancer , 77 , 1 – 6 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 23.Wilson , C. A. , Ramos , L. , Villasenor , M. R. , Anders , K. H. , Press , M. R , Clarke , K. , Karlan , B. , Chen , J. J. , Scully , R. , Livingston , D. , Zuch , R. H. , Kanter , M. H. , Cohen , S. , Calzone , F. J. and Slamon , D. J.Localization of human BRCA1 and its loss in high‐grade, non‐inherited breast carcinomas . Nat. Genet. , 21 , 236 – 240 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 24.Yoshikawa , K. , Honda , K. , Inamoto , T. , Shinohara , H. , Yamauchi , A. , Suga , K. , Okuyama , T. , Shimada , T. , Kodama , H. , Noguchi , S. , Gazdar , A. F. , Yamaoka , Y. and Takahashi , R.Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCAl‐associated cases . Clin. Cancer Res. , 5 , 1249 – 1261 ( 1999. ). [PubMed] [Google Scholar]
  • 25.Miyoshi , Y. , Iwao , K. , Takahashi , Y. , Egawa , C. and Noguchi , S . Acceleration of chromosomal instability by loss of BRCA1 expression and p53 abnormality in sporadic breast cancers . Cancer Lett. , 159 , 211 – 216 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 26.Gudmundsson , J. , Johannesdottir , G. , Bergthorsson , J. T. , Arason , A. , Ingvarsson , S. , Egilsson , V. and Barkardottir , R. B . Different tumor types from BRCA2 carriers show wild‐type chromosome deletions on 13ql2‐ql3 . Cancer Res. , 55 , 4830 – 4832 ( 1995. ). [PubMed] [Google Scholar]
  • 27.Marcus , J. N. , Watson , P. , Page , D. L. , Narod , S. A. , Lenoir , G. M. , Tonin , P. , Linder‐Stephenson , L. , Salerno , G. , Conway , T. A. and Lynch , H. T . Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage . Cancer , 77 , 697 – 709 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 28.Marcus , J. N. , Watson , P. , Page , D. L. , Narod , S. A. , Tonin , P. , Lenoir , G. M. , Serova , O. and Lynch , H. T . BRCA2 hereditary breast cancer pathophenotype . Breast Cancer Res. Treat. , 44 , 275 – 277 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 29.Rajan , J. V. , Wang , M. , Marquis , S. T. and Chodosh , L. A . Brca2 is coordinately regulated with Brcal during proliferation and differentiation in mammary epithelial cells . Proc. Natl. Acad. Sci. USA , 93 , 13078 – 13083 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Vaughn , J. P. , Cirisano , F. D. , Huper , G. , Berchuck , A. , Futreal , P. A. , Marks , J. R. and Iglehart , J. D . Cell cycle control of BRCA2 . Cancer Res. , 56 , 4590 – 4594 ( 1996. ). [PubMed] [Google Scholar]
  • 31.Spillman , M. A. and Bowcock , A. M . BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen . Oncogene , 13 , 1639 – 1645 ( 1996. ). [PubMed] [Google Scholar]
  • 32.Russell , P. A. , Pharoah , P. D. P. , De Foy , K. , Ramus , S. J. , Symmonds , I. , Wilson , A. , Scott , I. , Ponder , B. A. J. and Gayther , S. A . Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers . Int. J. Cancer , 87 , 317 – 321 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 33.Rio , P. G. , Maurizis , J. C. , Peffault de Latour , M. , Bignon , Y. J. and Bernard‐Gallon , D. J . Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene . Int. J. Cancer , 80 , 823 – 826 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 34.Bernard‐Gallon , D. , Peffault De Latour , M. , Rio , P. , Favy , D. , Hizel , C. , Vissac , C. and Bignon , Y. J . BRCA2 protein expression in sporadic breast carcinoma with or without allelic loss of BRCA2 . Int. J. Cancer , 86 , 453 – 456 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 35.Beckmann , M. W. , Picard , F. , An , H. X. , van Roeyen , C. R. C. , Dominik , S. L , Mosny , D. S. , Schnurch , H. G. , Bender , H. G. and Niederacher , D . Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer . Br. J. Cancer , 73 , 1220 – 1226 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES